Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Teladoc Health, Inc. | 4LL | Nov 29, 2024 | 11.34 | +1.32 |
Tele2 ADR B | NCY | Nov 29, 2024 | 4.86 | +0.41 |
Tele2 B | NCYD | Nov 29, 2024 | 9.93 | +0.18 |
Telecom Argentina SA | TEO | Nov 29, 2024 | 12.40 | 0.00 |
Telecom Italia S.p.A. | TQIA | Nov 29, 2024 | 2.22 | -1.77 |
Telecom Italia S.p.A. | TQI1 | Nov 29, 2024 | 2.54 | -1.55 |
Telecom Italia S.p.A. PRF PERPETUAL EUR 0.55 | TQIR | Nov 29, 2024 | 0.26 | -1.68 |
Telecom Italia SpA/Milano | TQI | Nov 29, 2024 | 0.23 | -1.48 |
Telecom Plus PLC | T8T | Nov 29, 2024 | 21.00 | 0.00 |
Teledyne Technologies Inc | TYZ | Nov 29, 2024 | 457.90 | +0.07 |
Teleflex Incorporated | TBH | Nov 29, 2024 | 179.00 | -0.56 |
Telefonica Brasil S.A. American Depositary Shares (Each repr | TSPA | Nov 29, 2024 | 8.05 | 0.00 |
Telefonica S.A | TNE5 | Nov 29, 2024 | 4.29 | -1.56 |
Telefonica SA | TNE2 | Nov 29, 2024 | 4.28 | +0.47 |
Telekom Austria AG | TA1 | Nov 29, 2024 | 7.77 | +0.52 |
Telenor | TEQ | Nov 29, 2024 | 11.19 | +1.63 |
Teleperformance | RCF | Nov 29, 2024 | 88.46 | -0.85 |
TELEPERFORMANCE SA | RCF0 | Nov 29, 2024 | 42.80 | +2.39 |
Telesat | ZE2 | Nov 29, 2024 | 12.80 | -0.78 |
Teleste | TS6 | Nov 29, 2024 | 2.38 | +3.48 |
Telia Company | TLS | Nov 29, 2024 | 2.79 | +1.05 |
Telia Company AB | TLSG | Nov 29, 2024 | 5.30 | -0.93 |
Telia Lietuva | ZWS | Nov 29, 2024 | 1.54 | 0.00 |
TELIX PHARMACEUTICALS LTD | T3X | Nov 29, 2024 | 15.45 | +4.39 |
Telkom SA SOC Ltd | TZL1 | Nov 29, 2024 | 1.69 | +2.42 |
Tellusgruppen | 7FW | Nov 29, 2024 | 0.54 | -6.90 |
Telo Genomics Corp | 3D0A | Nov 29, 2024 | 0.03 | -52.14 |
TELSTRA GROUP LTD | 5KBA | Nov 29, 2024 | 2.38 | -1.61 |
Telus Corp. | BCZ | Nov 29, 2024 | 14.50 | -0.68 |
TELUS International (Cda) Inc | 5Z9 | Nov 29, 2024 | 3.64 | +0.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.